Veeva Systems Inc. (0LO3.L)
USD 224.84
(-0.5%)
USD 224.84
(-0.5%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 1.68 Billion USD | 9.1% |
| 2023 | 1.54 Billion USD | 14.74% |
| 2022 | 1.34 Billion USD | 27.55% |
| 2021 | 1.05 Billion USD | 31.9% |
| 2020 | 800.71 Million USD | 29.79% |
| 2019 | 616.92 Million USD | 30.12% |
| 2018 | 474.13 Million USD | 28.02% |
| 2017 | 370.36 Million USD | 38.71% |
| 2016 | 267 Million USD | 35.15% |
| 2015 | 197.56 Million USD | 54.89% |
| 2014 | 127.54 Million USD | 75.85% |
| 2013 | 72.53 Million USD | 125.21% |
| 2012 | 32.2 Million USD | 91.57% |
| 2011 | 16.81 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 453.05 Million USD | 0.94% |
| 2024 Q1 | 359.66 Million USD | -9.88% |
| 2024 Q2 | 421.2 Million USD | 17.11% |
| 2024 FY | 1.67 Billion USD | 8.17% |
| 2024 Q3 | 448.82 Million USD | 6.56% |
| 2023 Q3 | 398.44 Million USD | 4.16% |
| 2023 Q1 | 365.58 Million USD | 4.57% |
| 2023 FY | 1.54 Billion USD | 14.74% |
| 2023 Q2 | 382.54 Million USD | 4.64% |
| 2023 Q4 | 399.07 Million USD | 0.16% |
| 2022 Q4 | 349.61 Million USD | 0.89% |
| 2022 Q2 | 333.49 Million USD | 5.06% |
| 2022 Q1 | 317.43 Million USD | 12.2% |
| 2022 FY | 1.34 Billion USD | 27.55% |
| 2022 Q3 | 346.54 Million USD | 3.91% |
| 2021 Q4 | 282.91 Million USD | 3.06% |
| 2021 FY | 1.05 Billion USD | 31.9% |
| 2021 Q1 | 242.22 Million USD | 11.53% |
| 2021 Q3 | 274.52 Million USD | 7.03% |
| 2021 Q2 | 256.47 Million USD | 5.88% |
| 2020 Q1 | 179.24 Million USD | 6.82% |
| 2020 Q3 | 207.59 Million USD | 5.55% |
| 2020 FY | 800.71 Million USD | 29.79% |
| 2020 Q4 | 217.18 Million USD | 4.62% |
| 2020 Q2 | 196.68 Million USD | 9.73% |
| 2019 FY | 616.92 Million USD | 30.12% |
| 2019 Q4 | 167.79 Million USD | 2.72% |
| 2019 Q3 | 163.35 Million USD | 8.63% |
| 2019 Q2 | 150.38 Million USD | 11.07% |
| 2019 Q1 | 135.39 Million USD | 7.45% |
| 2018 FY | 474.13 Million USD | 28.02% |
| 2018 Q3 | 122.91 Million USD | 5.79% |
| 2018 Q4 | 126 Million USD | 2.51% |
| 2018 Q1 | 109.03 Million USD | 5.16% |
| 2018 Q2 | 116.18 Million USD | 6.55% |
| 2017 Q1 | 78.67 Million USD | 5.56% |
| 2017 Q4 | 103.68 Million USD | 4.88% |
| 2017 FY | 370.36 Million USD | 38.71% |
| 2017 Q3 | 98.85 Million USD | 10.88% |
| 2017 Q2 | 89.15 Million USD | 13.32% |
| 2016 Q2 | 64.63 Million USD | 11.56% |
| 2016 Q1 | 57.93 Million USD | 3.73% |
| 2016 FY | 267 Million USD | 35.15% |
| 2016 Q4 | 74.52 Million USD | 6.6% |
| 2016 Q3 | 69.9 Million USD | 8.16% |
| 2015 FY | 197.56 Million USD | 54.89% |
| 2015 Q4 | 55.85 Million USD | 4.58% |
| 2015 Q3 | 53.4 Million USD | 12.37% |
| 2015 Q2 | 47.52 Million USD | 16.57% |
| 2015 Q1 | 40.77 Million USD | 6.05% |
| 2014 Q2 | 30.43 Million USD | 21.37% |
| 2014 FY | 127.54 Million USD | 75.85% |
| 2014 Q3 | 33.58 Million USD | 10.35% |
| 2014 Q4 | 38.44 Million USD | 14.46% |
| 2014 Q1 | 25.07 Million USD | 8.91% |
| 2013 Q4 | 23.02 Million USD | 15.48% |
| 2013 Q3 | 19.94 Million USD | 0.0% |
| 2013 FY | 72.53 Million USD | 125.21% |
| 2012 FY | 32.2 Million USD | 91.57% |
| 2011 FY | 16.81 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -735.898% |
| Accuray Incorporated | 143.12 Million USD | -1078.291% |
| Align Technology, Inc. | 2.72 Billion USD | 38.004% |
| Elevance Health Inc. | 47.01 Billion USD | 96.413% |
| AxoGen, Inc. | 127.87 Million USD | -1218.784% |
| Boston Scientific Corporation | 9.84 Billion USD | 82.878% |
| CVS Health Corporation | 54.43 Billion USD | 96.902% |
| Cardinal Health, Inc. | 7.41 Billion USD | 77.254% |
| Centene Corporation | 153.99 Billion USD | 98.905% |
| DaVita Inc. | 3.82 Billion USD | 55.859% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 96.938% |
| Hologic, Inc. | 2.23 Billion USD | 24.641% |
| Humana Inc. | 106.44 Billion USD | 98.416% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 22.995% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | 49.883% |
| Masimo Corporation | 1 Billion USD | -68.05% |
| McKesson Corporation | 12.58 Billion USD | 86.599% |
| Patterson Companies, Inc. | 1.38 Billion USD | -22.18% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | 43.047% |
| ResMed Inc. | 2.6 Billion USD | 35.357% |
| Henry Schein, Inc. | 3.65 Billion USD | 53.81% |
| Teladoc Health, Inc. | 1.84 Billion USD | 8.467% |
| Universal Health Services, Inc. | 1.17 Billion USD | -43.475% |
| Baxter International Inc. | 4.97 Billion USD | 66.103% |
| Becton, Dickinson and Company | 8.82 Billion USD | 80.887% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 64.343% |
| Danaher Corporation | 14.12 Billion USD | 88.064% |
| Stryker Corporation | 13.05 Billion USD | 87.085% |
| Medtronic plc | 21.27 Billion USD | 92.073% |